High-dose chemotherapy with autologous stem cell support does not improve outcome in the first-line treatment of aggressive non-Hodgkin lymphoma - Results of a comprehensive meta-analysis

被引：0
|
作者：
Greb, A
Bohlius, J
Schwarzer, G
Schiefer, D
Engert, A
机构：
[1] German Cochrane Ctr, Inst Med Biometry & Med Informat, Freiburg, Germany
[2] Univ Cologne, Dept Internal Med 1, Cochrane Haematol Malignancies Grp, Cologne, Germany
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
068
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [21] Comparison of the sequential high-dose chemotherapy followed by autologous stem cell support with and without rituximab in relapsed and refractory aggressive non-Hodgkin's lymphoma.
    Sieniawski, M
    Staak, JO
    Scheuss, H
    Glossmann, JP
    Diehl, V
    Engert, A
    Josting, A
    BLOOD, 2004, 104 (11) : 263A - 263A
  • [22] AUTOLOGOUS STEM CELL TRANSPLANTATION AS FRONT LINE THERAPY DOES NOT IMPROVE THE OUTCOME OF HIGH RISK AGGRESSIVE NON-HODGKIN'S LYMPHOMA: A SINGLE CENTER STUDY
    Won, J. -H
    Yun, J.
    Kim, H. J.
    Kim, K. H.
    Kim, S. -H
    Lee, S. -C
    Kim, H. J.
    Bae, S. B.
    Kim, C. K.
    Lee, N. S.
    Lee, K. -T
    Park, S. K.
    Hong, D. S.
    Park, H. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S252 - S252
  • [23] High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma
    Haioun, C
    Lepage, E
    Gisselbrecht, C
    Coiffier, B
    Doyen, C
    Morel, P
    Attal, M
    Tilly, H
    Deconinck, E
    Gaulard, P
    Reyes, F
    ANNALS OF ONCOLOGY, 1998, 9 : 5 - 8
  • [24] First-Line High-Dose Therapy and Autologous Blood Stem Cell Transplantation in Patients with Primary CNS Non-Hodgkin Lymphomas
    Brezina, Tomas
    von Dewitz, Helena
    Kondakci, Mustafa
    Dienst, Ariane
    Schroeder, Thomas
    Ullrich, Sebastian
    Rautenberg, Christina
    Nachtkamp, Kathrin
    Reifenberger, Guido
    Malzkorn, Bastian
    Sabel, Michael
    Haas, Rainer
    Kobbe, Guido
    BONE MARROW TRANSPLANTATION, 2018, 53 : 609 - 609
  • [25] High-dose Chemotherapy (HDC) with rituximab and autologous stem cell support in patients with poor prognosis non-Hodgkin's lymphoma (NHL)
    Ptushkin, V
    Mheidze, D
    Larionova, V
    Zukov, N
    Andreeva, L
    Osmanov, E
    Chimishkyan, K
    BONE MARROW TRANSPLANTATION, 2002, 29 : S95 - S95
  • [26] Outcome of primary refractory Hodgkin lymphoma with high-dose chemotherapy and autologous stem cell transplantation
    Akhtar, S
    El Weshi, A
    Rahal, M
    Abdelsalam, M
    Janabi, L
    Hussaini, H
    Maghfoor, I
    BONE MARROW TRANSPLANTATION, 2006, 37 : S239 - S239
  • [27] Autologous stem cell transplantation improve outcome in non-Hodgkin's lymphoma: results of a computer science analysis
    Pelosini, M.
    Baronti, F.
    Galimberti, S.
    Caracciolo, F.
    Benedetti, E.
    Papineschi, F.
    Starita, A.
    Petrini, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S212 - S213
  • [28] High-dose chemotherapy and autologous stem cell transplantation as first-line treatment without consolidating radiotherapy for primary CNS lymphoma
    Illerhaus, G.
    Mueller, F.
    Marks, R.
    Ostertag, C.
    Finke, J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S148 - S148
  • [29] High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)
    Oyan, B
    Koc, Y
    Ozdemir, E
    Kansu, E
    BLOOD, 2004, 104 (11) : 393B - 393B
  • [30] High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma:: results of a multicenter phase II study
    Josting, A
    Sieniawski, M
    Glossmann, JP
    Staak, O
    Nogova, L
    Peters, N
    Mapara, M
    Dörken, B
    Ko, Y
    Metzner, B
    Kisro, J
    Diehl, V
    Engertl, A
    ANNALS OF ONCOLOGY, 2005, 16 (08) : 1359 - 1365
12345